share_log

友邦保險：授出購股權

AIA: Grant of Share Options

HKEX ·  Mar 19 21:17
Summary by Futu AI
友邦保險於2024年3月19日宣佈，根據其於2020年5月29日採納的購股權計劃（經修訂），向其僱員、董事及主管授出共3,019,542份購股權。該購股權授予承授人以收取相等於認購價與市價差額的本公司新普通股或等額現金。行使價為每股62.33港元，而授出當日股份收市價為每股57.40港元。購股權的歸屬期為2024年3月19日至2027年3月18日，行使期則為2027年3月19日至2034年3月18日。本次授出購股權旨在鼓勵長期發展及為股東創造價值，並無設定表現目標。若出現重大失實財務報表或其他重大失實表現準則等情況，購股權可被收回或失效。本公司執行董事、集團首席執行官兼總裁李源祥獲授808,729份購股權，其他合資格僱員則獲授2,210,813份。
友邦保險於2024年3月19日宣佈，根據其於2020年5月29日採納的購股權計劃（經修訂），向其僱員、董事及主管授出共3,019,542份購股權。該購股權授予承授人以收取相等於認購價與市價差額的本公司新普通股或等額現金。行使價為每股62.33港元，而授出當日股份收市價為每股57.40港元。購股權的歸屬期為2024年3月19日至2027年3月18日，行使期則為2027年3月19日至2034年3月18日。本次授出購股權旨在鼓勵長期發展及為股東創造價值，並無設定表現目標。若出現重大失實財務報表或其他重大失實表現準則等情況，購股權可被收回或失效。本公司執行董事、集團首席執行官兼總裁李源祥獲授808,729份購股權，其他合資格僱員則獲授2,210,813份。
AIA announced on 19 March 2024 that it has granted 3,019,542 share options to its employees, directors and directors under its share option plan adopted on 29 May 2020 (as amended). The share option grants the grantor to receive cash in the Company's new ordinary shares or equivalents equal to the subscription price and the market price difference. The exercise price was HK$62.33 per share and the issued closing price of the shares was HK$57.40 per share on the day of issue. The vesting period for the share rights is 19 March 2024 to 18 March 2027 and the exercise period is 19 March 2027 to 18 March 2034. This grant of share rights is intended to encourage long-term development and create value for shareholders without setting performance targets. In the event of a material failure in the financial statements or other major performance criteria, the purchase option may be revoked or voided. The Company's Executive Director, Group Chief Executive Officer and President Li Yuanxiang was granted 808,729 share options and other eligible employees were granted 2,210,813 shares.
AIA announced on 19 March 2024 that it has granted 3,019,542 share options to its employees, directors and directors under its share option plan adopted on 29 May 2020 (as amended). The share option grants the grantor to receive cash in the Company's new ordinary shares or equivalents equal to the subscription price and the market price difference. The exercise price was HK$62.33 per share and the issued closing price of the shares was HK$57.40 per share on the day of issue. The vesting period for the share rights is 19 March 2024 to 18 March 2027 and the exercise period is 19 March 2027 to 18 March 2034. This grant of share rights is intended to encourage long-term development and create value for shareholders without setting performance targets. In the event of a material failure in the financial statements or other major performance criteria, the purchase option may be revoked or voided. The Company's Executive Director, Group Chief Executive Officer and President Li Yuanxiang was granted 808,729 share options and other eligible employees were granted 2,210,813 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.